[Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. increased its capital to 490 million yuan, an increase of approximately 121%] On October 28, Tianyancha showed that Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. had recently undergone industrial and commercial changes, and its registered capital increased from 220 million yuan to approximately 490 million yuan, an increase of approximately 121%. The company was established in September 2006. Its legal representative is Peng Shaoping. Its business scope includes drug production, drug entrustment production, drug wholesale, etc. It is jointly held by Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd., Shanghai Fosun Pharmaceutical Industry Development Co., Ltd., and FOSUN INDUSTRIAL CO., LIMITED, a subsidiary of Fosun Pharma.